Ulla Buhl Overview
Ulla Buhl General Information
Biography
Ms. Ulla Buhl serves as Chief Executive Officer at AIDA. She serves as Chief Operating Officer and Board Member at Chosa Oncology. She previously served as Chief Operating Officer & Chief, Investor Relations and Communications at Oncology Venture Sweden. She served as Chief Creative Officer at LiPlasome Pharma. Ms. Ulla served as Board Member at Oncology Venture US. She has a broad competence within diverse areas, including extensive experience in running clinical trials, organization management, and corporate communications. She has conducted financial communications for listed companies in Denmark and Sweden since 2006, and previously managed the Investor Relations departments of TopoTarget A/S and WntResearch AB. Hald Buhl is currently active within this field for Oncology Venture as well as Danish Medical Prognosis Institute A/S. From 2010-2016, Hald Buhl was responsible for Clinical Operations at WntResearch while concurrently managing the company's IR, PR and corporate communications. She was closely involved in raising capital for WntResearch, and in listing the company on the stock market. Hald Buhl was previously with TopoTarget A/S, where during her nine-year tenure she formed and led departments in the positions of Quality Manager, International Regulatory Manager, Head of Pharmacovigilance, Director of Investor Relations, and Director of PR, in which role she was responsible for both internal and external communications. As a member of TopoTarget's management team, Hald Buhl was closely involved in capital raises and financial reporting. Prior to TopoTarget, Hald Buhl was National Study Team Leader of Oncology Trials in Denmark for AstraZeneca A/S.
Contact Information
Address
- Skovhegnet 9
- 3460 Birkerød
- Denmark
Ulla Buhl Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
AIDA (Biotechnology) | Company | Chief Executive Officer | Birkerød, Denmark | Biotechnology | |
Chosa Oncology | Company | Chief Operating Officer & Board Member | Lund, Sweden | Drug Discovery |
Ulla Buhl Board Seats (1)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Chosa Oncology | Drug Discovery | Publicly Held | Corporation | Lund, Sweden |
Ulla Buhl Network (4)
Board Members (4)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Chosa Oncology | Self | Lund, Sweden |
Ulla Buhl FAQs
-
Who is Ulla Buhl?
Ms. Ulla Buhl serves as Chief Executive Officer at AIDA.
-
How much does Ulla Buhl typically invest?
Ulla Buhl's median deal size is
. -
What is Ulla Buhl’s main position?
Ulla Buhl’s primary position is Chief Executive Officer.
-
How many active board seats does Ulla Buhl hold?
Ulla Buhl holds a board seat in Chosa Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »